All In Biotech

Drug Trial Radar · NCT07789574

Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Jun 30, 2030

Study completion Dec 31, 2030

Sponsor

Lead sponsor
Thomas Ernst, Prof. Dr. med.Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, prospective, single-arm, non-randomized, interventional phase II study of CML patients in first or second chronic phase (i.e. after allogeneic stem cell transplantation) and proven BCR::ABL1 T315I mutation. All patients will be treated with asciminib 200 mg BID. 50 patients will be enrolled from approximately 20 study sites in Germany.

Conditions

  • Chronic Myeloid Leukemia (CML)

Interventions

  • asciminib 200 mg BIDDrug

    All patients will be treated with asciminib 200 mg BID.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of MR2 at 12 monthsTime frame: 12 months after start of therapy

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Uniklinik der RWTH Aachen

    Aachen, Germany · Recruiting

  • Charite CVK

    Berlin, Germany · Not yet recruiting

  • Klinikum Chemnitz gGmbH

    Chemnitz, Germany · Not yet recruiting

  • Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden

    Dresden, Germany · Not yet recruiting

  • Universitätsklinikum Hamburg-Eppendorf

    Hamburg, Germany · Not yet recruiting

  • Medizinische Hochschule Hannover

    Hanover, Germany · Not yet recruiting

  • Universitätsklinikum Jena

    Jena, Germany · Recruiting

  • Universitätsklinikum Leipzig AöR

    Leipzig, Germany · Recruiting

  • Medizinische Fakultät Mannheim der Universität Heidelberg

    Mannheim, Germany · Recruiting

  • Universitätsklinikum Ulm

    Ulm, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.